HomeRLAY • NASDAQ
add
Relay Therapeutics Inc
Previous close
$7.49
Day range
$7.53 - $7.92
Year range
$1.78 - $8.36
Market cap
1.37B USD
Avg Volume
2.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.50M | -36.70% |
Net income | -74.15M | 15.84% |
Net profit margin | — | — |
Earnings per share | -0.43 | 31.75% |
EBITDA | -79.64M | 16.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 596.43M | -28.96% |
Total assets | 670.00M | -27.97% |
Total liabilities | 62.29M | -31.74% |
Total equity | 607.71M | — |
Shares outstanding | 173.32M | — |
Price to book | 2.13 | — |
Return on assets | -28.73% | — |
Return on capital | -29.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -74.15M | 15.84% |
Cash from operations | -62.12M | 17.27% |
Cash from investing | 39.72M | 131.49% |
Cash from financing | 17.00K | -99.99% |
Net change in cash | -22.38M | -226.82% |
Free cash flow | -37.97M | 14.75% |
About
Founded
2015
Website
Employees
188
